Capital Flow Monitor · Sponsors · CIK 2138892
Catalio Inflection Fund III, LLC
512 W. 22ND STREET, NEW YORK, NY, 10011 · 917-832-1832
Pooled Investment Fund / Private Equity Fund · Limited Liability Company· inc. DELAWARE true 2026
Fit score
—
Offering
$8.0M
Sold
$8.0M
% sold
100.0%
Investors
12
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-06-10 | D ·current | 506(b) | $8.0M | $8.0M | 100.0% | 12 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
- Catalio Inflection Manager I, LLC — Promoter, New York, NY
1 other raise
- Catalio Inflection Fund II, LLC $10.0M of $10.0M · 100.0%
-
George Petrocheilos — Executive Officer, New York, NY
13 other raises
- Catalio Access Fund XII, LLC $20.1M of $20.1M · 100.0%
- Catalio Access Fund XI, LLC $16.3M of $16.3M · 100.0%
- Catalio Access Fund IX, LLC $17.3M of $17.3M · 100.0%
- Catalio Inflection Fund II, LLC $10.0M of $10.0M · 100.0%
- Catalio Structured Opportunities Offshore Fund II, LP $122.8M of —
- Catalio Structured Opportunities Fund II, LP $179.3M of —
- Catalio Genesis Fund X, LLC $19.1M of $19.1M · 100.0%
- Catalio Access Fund X, LLC $20.3M of $20.3M · 100.0%
- Catalio Access Fund VIII, LLC $25.0M of $25.0M · 100.0%
- Catalio Public Equities Offshore Fund, Ltd. $142.1M of —
- Catalio Public Equities Fund, LP $83.9M of —
- Catalio Nexus Fund IV, LP $357.6M of —
- Catalio Genesis Fund IX, LLC $8.6M of $8.6M · 100.0%
-
R. Jacob Vogelstein — Executive Officer, New York, NY
15 other raises
- Catalio Access Fund XII, LLC $20.1M of $20.1M · 100.0%
- NextPoint Therapeutics, Inc. $33.7M of $48.7M · 69.2%
- Catalio Access Fund XI, LLC $16.3M of $16.3M · 100.0%
- Catalio Access Fund IX, LLC $17.3M of $17.3M · 100.0%
- Catalio Inflection Fund II, LLC $10.0M of $10.0M · 100.0%
- Catalio Structured Opportunities Offshore Fund II, LP $122.8M of —
- Catalio Structured Opportunities Fund II, LP $179.3M of —
- Catalio Genesis Fund X, LLC $19.1M of $19.1M · 100.0%
- Catalio Access Fund X, LLC $20.3M of $20.3M · 100.0%
- Catalio Access Fund VIII, LLC $25.0M of $25.0M · 100.0%
- Catalio Public Equities Offshore Fund, Ltd. $142.1M of —
- Catalio Public Equities Fund, LP $83.9M of —
- Catalio Nexus Fund IV, LP $357.6M of —
- Iambic Therapeutics, Inc. $99.3M of $125.0M · 79.4%
- Catalio Genesis Fund IX, LLC $8.6M of $8.6M · 100.0%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.